Last updated on March 2017

"An Open Label Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines"


Brief description of study

"An Open Label Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines"

Detailed Study Description

An evaluation of long term safety of repeat ALD403 doses in Chronic Migraine

Clinical Study Identifier: TX148114

Find a site near you

Start Over

Cedar Crosse Research Center

800 S Wells, Suite M15 Chicago, IL USA
  Connect »